Abstract
Primary pulmonary hypertension (PPH), characterized by obstruction of pre-capillary pulmonary arteries, leads to sustained elevation of pulmonary arterial pressure (mean >25 mm Hg at rest or >30 mm Hg during exercise1). The aetiology is unknown, but the histological features reveal proliferation of endothelial and smooth muscle cells with vascular remodelling2 (Fig. 1). More than one affected relative has been identified in at least 6% of cases3 (familial PPH, MIM 178600). Familial PPH (FPPH) segregates as an autosomal dominant disorder with reduced penetrance and has been mapped to a locus designated PPH1 on 2q33, with no evidence of heterogeneity4,5,6. We now show that FPPH is caused by mutations in BMPR2, encoding a TGF-β type II receptor (BMPR-II). Members of the TGF-β superfamily transduce signals by binding to heteromeric complexes of type I and II receptors, which activates serine/threonine kinases, leading to transcriptional regulation by phosphorylated Smads7. By comparison with in vitro studies, identified defects of BMPR-II in FPPH are predicted to disrupt ligand binding, kinase activity and heteromeric dimer formation8,9,10. Our data demonstrate the molecular basis of FPPH and underscore the importance in vivo of the TGF-β signalling pathway in the maintenance of blood vessel integrity.
†These authors contributed equally to this work. *Micheala Aldred2, Christopher A. Brannon3, P. Michael Conneally4, Tatiana Foroud4, Neale Fretwell2, Radhika Gaddipati1, Daniel Koller4, Emily J. Loyd1, Neil Morgan2, John H. Newman1, Melissa A. Prince1, Carles Vilariño Güell2 & Lisa Wheeler1 1Vanderbilt University Medical Center, Nashville, Tennessee, USA. 2Division of Medical Genetics, Departments of Genetics and Medicine, University of Leicester, UK. 3Division of Human Genetics, Children's Hospital Medical Center, Cincinnati, Ohio, USA. 4Indiana University School of Medicine, Indianapolis, Indiana, USA. Correspondence should be addressed to J.E.L. (e-mail: Jim.Loyd@mcmail.vanderbilt.edu), W.C.N. (e-mail: bill.nichols@chmcc.org) or R.C.T. (e-mail: rtrembat@hgmp.mrc.ac.uk).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Rubin, L. ACCP consensus statement: primary pulmonary hypertension. Chest 104, 236–250 ( 1993).
Gaine, S.P. & Rubin, L.J. Primary pulmonary hypertension. Lancet 352, 719–725 ( 1998).
Rich, S. et al. Primary pulmonary hypertension: a national prospective study. Ann. Intern. Med. 107, 216–223 (1987).
Loyd, J.E., Primm, R.K. & Newman, J.H. Familial primary pulmonary hypertension: clinical patterns. Am. Rev. Respir. Dis. 129, 194 –197 (1984).
Nichols, W.C. et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32. Nature Genet. 15, 277–280 (1997).
Morse, J.H. et al. Mapping of familial pulmonary hypertension locus (PPH1 ) to chromosome 2q31–32. Circulation 95, 2603–2606 (1997).
Massagué, J. & Chen, Y.-G. Controlling TGF-β signalling. Genes Dev. 14, 627– 644 (2000).
Wrana, J.L. et al. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol. Cell. Biol. 14, 944–950 (1994).
Carcamo, J., Zentella, A. & Massagué, J. Disruption of transforming growth factor β signalling by a mutation that prevents transphosphorylation within the receptor complex . Mol. Cell. Biol. 15, 1573– 1581 (1995).
Gilboa, L. et al. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors . Mol. Biol. Cell. 11, 1023– 1035 (2000).
Hadano, S. et al. A yeast artificial chromosome-based physical map of the juvenile amyotrophic lateral sclerosis (ALS2) critical region on human chromosome 2q33–q34 . Genomics 55, 106–112 (1999).
Machado, R.D. et al. A physical and transcript map based upon refinement of the critical interval for PPH1, a gene for familial primary pulmonary hypertension . Genomics (in press).
Kawabata, M., Chytil, A. & Moses, H.L. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-β receptor . J. Biol. Chem. 270, 5625– 5630 (1995).
Liu, F., Ventura, F., Doody, J. & Massagué, J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 15, 3479–3486 (1995).
Rosenzweig, B.L. et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl Acad. Sci. USA 92, 7632–7636 (1995).
Botney, M.D., Bahadori, L. & Gold, L.I. Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-β. Am. J. Pathol. 144, 286–295 ( 1994).
Marchuk, D.A. Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr. Opin. Hematol. 5, 332–338 (1998).
Beppu, H., Minowa, O., Miyazono, K. & Kawabata, M. cDNA cloning and genomic organization of the mouse BMP type II receptor. Biochem. Biophys. Res. Commun. 235, 499–504 (1997).
Wilkie, A.O. The molecular basis of genetic dominance. J. Med. Genet. 31, 89–98 (1994).
Thomson, J.R. & Trembath, R.C. Primary pulmonary hypertension: the pressure rises for a gene. J. Clin. Pathol. (in press).
Lu, S.L. et al. HNPCC associated with germline mutation in the TGF-β type II receptor gene. Nature Genet. 19, 17– 18 (1998).
Lee, S.D. et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J. Clin. Invest. 101, 927–934 (1998).
Shackleton, S. et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy . Nature Genet. 24, 153– 156 (2000).
Acknowledgements
We thank the patients and families for participation; the Pulmonary Hypertension Association for encouragement and support; clinicians and colleagues who provided patient information, including R. Allcock, P. Corris, K. McNeil, C. Peels, D. Williams and Sir M. Yacoub; S. Shackleton for critical reading of the manuscript; and D. Lloyd for assistance with the figures. This work has financial support from the British Heart Foundation (R.C.T., Project grant), the American Heart Association (K.B.L., 9820010SE) and the National Institutes of Health (W.C.N., HL61997; J.E.L., HL48164, HL61997). J.R.T. is a Medical Research Council (UK) Clinical Training Fellow.
Supplementary information
Rights and permissions
About this article
Cite this article
Lane, K., Machado, R., Pauciulo, M. et al. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 26, 81–84 (2000). https://doi.org/10.1038/79226
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/79226
This article is cited by
-
Pulmonary hypertension
Nature Reviews Disease Primers (2024)
-
Sotatercept in pulmonary arterial hypertension: something different or more of the same?
Nature Cardiovascular Research (2023)
-
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study
Hepatology International (2023)
-
New progress in diagnosis and treatment of pulmonary arterial hypertension
Journal of Cardiothoracic Surgery (2022)
-
KLF4 recruits SWI/SNF to increase chromatin accessibility and reprogram the endothelial enhancer landscape under laminar shear stress
Nature Communications (2022)